Physician profile
Charles A Ternent
NPI 1841289147
$6,631.99
in general payments reported to CMS, 2019-2025
24 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,710 · 2020: $323 · 2021: $1,248 · 2022: $234 · 2023: $219 · 2024: $346 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,099.26 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,910.28 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $618.31 | 2019-2020 | |
| Tela Bio, INC. | $302.73 | 2021-2022 | |
| Virtual Incision Corporation | $154.00 | 2024 | Mira |
| Ethicon US, LLC | $83.74 | 2019-2023 | Echelon; Endopath, Monocryl |
| Mallinckrodt Enterprises LLC | $73.34 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $53.03 | 2023-2024 | Gattex |
| Medtronic, INC. | $51.49 | 2023 | Gi Genius |
| Axonics, INC. | $49.70 | 2024 | Axonics |
| Integra Lifesciences Corporation | $44.38 | 2022-2024 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $39.25 | 2019 | |
| Kerecis Limited | $37.48 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $33.32 | 2025 | Axonics |
| Abbvie INC. | $28.50 | 2022 | |
| Ferring Pharmaceuticals INC. | $28.26 | 2019-2024 | Rebyota |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Northgate Technologies, INC. | $27.47 | 2024 | Stimsite |
| Covidien LP | $26.28 | 2019 | |
| Rti Surgical, INC | $20.02 | 2024 | |
| Cook Medical LLC | $18.42 | 2019 | |
| Smith+Nephew, INC. | $16.14 | 2023 | Renasys Go V2 Home, Pico |
| Hollister Incorporated | $15.85 | 2025 | New Image, Adapt Ceraring |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Ternent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.